Clinical significance of acute exacerbation in interstitial lung disease with antineutrophil cytoplasmic antibody: an indicator of poor prognosis.

Authors:
Wu T; Zhang Y; Cen Z; Ying Y; Sun C and 2 more

Journal:
Ther Adv Respir Dis

Publication Year: 2022

DOI:
10.1177/17534666221140974

PMCID:
PMC9742717

PMID:
36484348

Journal Information

Full Title: Ther Adv Respir Dis

Abbreviation: Ther Adv Respir Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article."

Evidence found in paper:

"Funding: The authors disclosed receipt of the following financial support for the research, authorship and/or publication of this article: This research was supported by the Zhejiang Provincial Natural Science Foundation of China under grant no. LBY22H180004 and the Natural Science Foundation of Ningbo under grant no. 2019A610228."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025